Results 161 to 170 of about 23,536 (264)

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Antimicrobial Agents and Chemotherapy, 2009
H. Azijn, Ilse Tirry, J. Vingerhoets, M. de Béthune, G. Kraus, K. Boven, Dirk Jochmans, E. Van Craenenbroeck, G. Picchio, L. Rimsky   +9 more
semanticscholar   +1 more source

Antiretroviral regimen switch and short-term viral suppression in persistent low-level viremia: A multicenter retrospective real-world cohort study in China. [PDF]

PLoS One
Liu H, Ren Y, Jia L, Wang L, Wang R, Yang T, Zhou Y, Zhao H, Dai L.   +8 more
europepmc   +1 more source

Multiclass HIV drug resistance: Case series of treatment-experienced PLHIV with resistance to all antiretroviral classes in Northern Uganda. [PDF]

IDCases
Kayinda F, Bakunzi LB, Okello E, Jurua C, Nasuuna EM.   +4 more
europepmc   +1 more source

Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV. [PDF]

AIDS
Mason J, Kohli M, Taiwo E, Maan I, Gharib Y, Suonpera E, Barlow M, Olcott F, Waters L, Arenas-Pinto A, Gilson R, Pett S.   +11 more
europepmc   +1 more source

Temporal shifts in antiretroviral therapy regimens and metabolic outcomes in people living with HIV: A systematic review and meta-analysis. [PDF]

HIV Med
Mahanani MR, Chit M, Mohr S, Cama I Gibernau E, Hetjens S, Winkler V, Steffen HM, Neuhann F.   +7 more
europepmc   +1 more source

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

Antiviral Therapy, 2012
T. Bunupuradah, P. Chetchotisakd, J. Ananworanich, Warangkana Munsakul, S. Jirajariyavej, P. Kantipong, W. Prasithsirikul, S. Sungkanuparph, C. Bowonwatanuwong, V. Klinbuayaem, S. Kerr, J. Sophonphan, Sorakij Bhakeecheep, B. Hirschel, K. Ruxrungtham   +14 more
semanticscholar   +1 more source

Stability and predictors of phenotypic age acceleration among virally suppressed Asians with HIV over five years. [PDF]

J Gerontol A Biol Sci Med Sci
Tang TH, Chan P, Kwong RT, Chan HS, Yung SK, Lam KW, Chu MY, Wu TC, Lam W, Leung WS, Ting WM, Fong JK, Choy AK, Tung JL, Yeung DK, Lee MP.   +15 more
europepmc   +1 more source

Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients.

Virology, 2012
P. Messiaen, C. Verhofstede, I. Vandenbroucke, Sylvie Dinakis, V. Van Eygen, K. Thys, B. Winters, J. Aerssens, D. Vogelaers, L. Stuyver, L. Vandekerckhove   +10 more
semanticscholar   +1 more source

Pretreatment HIV-1 drug resistance and molecular subtype characteristics among newly diagnosed individuals in Guangxi, China. [PDF]

AIDS Res Ther
Chen G, Hu M, Pan Y, Huang L, Dou Y, Sui W, Tang Y, Chen J, Liu A.   +8 more
europepmc   +1 more source

HIV-1 transmitted drug resistance in Shanghai, 2018-2024: population mobility shapes cross-population TDR transmission dynamics. [PDF]

Emerg Microbes Infect
Dong Y, Lin Q, Wang X, Liu C, Yu X, Tang W, Feng W, Lv X, Han Y, Yue Q, Ning Z, Shen X, Chen X, Zhou Y, Chen M, Wu H, Lin Y.   +16 more
europepmc   +1 more source